FDA Approved: SKYCLARYS — Supplemental Application (Biogen)

View source ↗

Summary

The FDA approved a supplemental application for SKYCLARYS (omaveloxolone) submitted by Biogen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• SKYCLARYS (omaveloxolone)

Snippet

SUPPL AP for SKYCLARYS (OMAVELOXOLONE)